ArticleBone marrow transplantation2025
Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil.
Victoria Stepanyants et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it